Moderna Stock Doubles on Cancer Breakthrough: Here’s What It Means
A Phase 3 win against the standard of care sent the biotech's shares up 131% and left short sellers down $4.8 billion.
- Nguồn
- Decrypt
- Đã đăng
- 2026-08-19 16:54 UTC
- Cập nhật cache
- 2026-08-19 17:01 UTC
Trang này chỉ hiển thị tiêu đề, tóm tắt và thông tin nguồn.
Mở bài gốc ↗Kiểm tra phí chuyểnChủ đề liên quan
01Users and Apps02Market and Policy
Decrypt
Follow consumer wallet, application, security, DeFi, and market updates before deciding whether Energy rental is needed.
Crypto Market, Regulation, and Stablecoin Policy News
Track crypto market, regulatory, stablecoin, and major-asset updates for broader blockchain context.